The Therapeutic Potential of Glutathione Supplement: A Review of Clinical Trials

##plugins.themes.bootstrap3.article.main##

  •   Abdelrahim Ahmad Hunaiti

Abstract

Glutathione (GSH) is a tripeptide (γ-glutamyl cysteinyl glycine) involved in a variety of biological processes indispensable to sustain life and the most abundant free radical scavenger synthesized endogenously in humans. There are adverse health consequences from glutathione deficiency. The present mini –review aims to provide an extensive overview to glutathione supplement therapeutic effects in human subjects. 


Keywords: Glutathione, Therapeutic Supplementation, Free radical scavenger

References

Aquilano, K., Baldelli, S., & Ciriolo, M. R. (2014). Glutathione: new roles in redox signaling for an old antioxidant. Frontiers in pharmacology, 5; 196.

He,L He,T. Farrar,S. Ji,L. Liu,T and Ma,X ( 2017) “Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species,” Cellular Physiology and Biochemistry, vol. 44, no. 2, pp. 532–553.

Castegna A, Lauderback C, Drake J. (2009) Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology. 7(1):65-74.

Bajic VP, Van Neste C, Obradovic M, Zafirovic S, Radak D, Bajic VB, et al.( . 2019) Glutathione “redox homeostasis” and its relation to cardiovascular disease. Oxidative Medicine and Cellular Longevity.1-14.

Ballatori N, Krana SM,Notenboom S, Shi S. Tien K, Hammont CL. (2009) Glutathione dysregulation and the etiology and progression of human diseases.Biol.Chem;39(3):191-214.

Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., and Zuo, L. (2017). Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid. Med. Cell. Longev.4:1-11.

Sekhar, R.V.; Patel, S.G.; Guthikonda, A.P.; Reid, M.; Balasubramanyam, A.; Taffet, G.E.; Jahoor, F. (2011) Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am. J. Clin. Nutr. 94, 847–853.

Rushworth, G.F.; Megson, I.L.( 2014) Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol. Ther., 141, 150–159.

Allen J, Bradley RD.(2011) Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. (9); 827-833.

Richie, J.P., Jr.; Nichenametla, S.; Neidig, W.; Calcagnotto, A.; Haley, J.S.; Schell, T.D.; Muscat, J.E. (2015) Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur. J. Nutr., 54, 251–263.

Sinha, R.; Sinha, I.; Calcagnotto, A.; Trushin, N.; Haley, J.S.; Schell, T.D.; Richie, J.P., Jr. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur. J. Clin. Nutr. 2018, 72, 105–111.

Schmitt B, Vicenzi M, Garrel C, Denis FM (2015). Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study. Redox Biology. 6:198-205.

Al-Shehabat, M.., Hani, I., Jaradat, S.. Alaraji ,A, and Hunaiti,A.(2017) Glutathione is a novel treatment for cystine stones.Comp Clin Pathol. 26, (3) 697-705

Casetta I , Govoni V , Granieri E (2005) Oxidative stress, antioxidants and neurodegenerative diseases. Curr Pharm Design 11, 2033–2052.

Cummings JL (2004) Drug therapy - Alzheimer’s disease. N Engl J Med 351, 56–67

Mandal PK , Saharan S , Tripathi M , Murari G (2015) Brain glutathione levels–a novel biomarker for mild cognitive impairment and Alzheimer’s disease. Biol Psychiatry 78, 702–710.

Butterfield DA , Pocernich CB , Drake J (2002) Elevated glutathione as a therapeutic strategy in Alzheimer’s disease. Drug Dev Res 56, 428–437.

Mandal, Pravat & Shukla, Deepika & Tripathi, Manjari & Ersland, Lars. (2019). Cognitive Improvement with Glutathione Supplement in Alzheimer's Disease: A Way Forward. Journal of Alzheimer's disease: JAD. 68. 531-535. 10.3233/JAD-181054

Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, Geier MR.( 2011) A clinical trial of glutathione supplementation in autism spectrum disorders. Med. Sci. Monit. 17(12): 677–682

Al-Omari,L , Abdelrahim A. Hunaiti, Mohammad A. Beirat and Bustanji,Y. (2019) Study of MTHFR C677T Polymorphism and Associated Oxidative Stress Biomarkers among Autism Spectrum Disorder Patients in Jordan. Jordan Journal of Biological Science (JJBS); Accepted August 29, 2019.will be published in Volume 13, Number 3 (September), 2020.

Homma T, Fuji i J. (2015) Application of Glutathione as Anti-Oxidative and Anti-Aging Drugs. Curr Drug Metab. 16(7):560-71.

Weschawalit, Sinee & Thongthip, Siriwan & Phutrakool, Phanupong & Asawanonda, Pravit. (2017). Glutathione and its antiaging and antimelanogenic effects. Clinical, Cosmetic and Investigational Dermatology. Volume 10. 147-153

Villarama CD, Maibach HI. (2005) Glutathione as a depigmenting agent: An overview. Int J Cosmet Sci.27:147-53

Watanabe F, Hashizume E, Chan GP, Kamimura A. ( 2014) Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women. Clin Cosmet Investig Dermatol.7:267–274.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Hunaiti, A. A. (2020). The Therapeutic Potential of Glutathione Supplement: A Review of Clinical Trials. European Journal of Medical and Health Sciences, 2(2). https://doi.org/10.24018/ejmed.2020.2.2.218